MedTrace Logo

The Journey of Children With Cow's Milk Protein Allergy in Mexico.

NCT04596059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2021-08-27

No results posted yet for this study

Summary

To gain insights on the application, use and effectiveness of Frisolac Gold Intensive HA and Frisolac Gold PEP AC with reference to improvement of CMPA symptoms and to determine the methodology used by Mexican Health Care Professionals (HCPs) in the clinical practice (i.e. diagnosis and dietary management) of CMPA in Mexican children (≤24 months) diagnosed with or suspected of CMPA.

Conditions

  • Cow's Milk Protein Allergy

Interventions

OTHER

Frisolac Gold Intensive HA

Regular medical care

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • FrieslandCampina

    lead INDUSTRY

Principal Investigators

  • Rosa E Huerta Hernandez, MD · Clínica de Alergia Pediátrica, México

  • Benjamin Zepeda Ortega, MD · Clinica San Antonio, Mexico

  • Marlene Ruiz Castillo, MD · Hospital del Niño DIF Hildago, Mexico; Consultorio de Pediatría Pachuca, Mexico

Eligibility

Min Age
0 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04596059 on ClinicalTrials.gov